Second Quarter Performance Better Than Expected The earnings season is upon us, and while everyone probably puts too much emphasis on short-term results and trends, in this environment everyone is waiting for good news, or at least news that things are better than...
Pays Big Premium For Antibody Technology Toward the end of July, Bristol-Myers Squibb (NYSE: BMY) and Medarex (NASDAQ: MEDX) announced that they had agreed to a merger in which BMY would acquire MEDX and its antibody-based therapeutics platform for $2.4 billion. No...
Higher Deal Volume Hints At End of Log-Jam During July the Long-Term Care sector posted a total of 10 deals involving 21 facilities. This marks the first time in 2009 that monthly deal volume in this sector has risen above six. We know that brokers, buyers and...
At Vintage Senior Living, their residents’ quality of life is always and everywhere uppermost on their staff’s minds-from the nutritious meals they plan, to the rewarding social life and diverse activities they encourage, to the beautiful surroundings and...